LeMaitre Vascular (LeMaitre Vascular) Total Inventories : $52.3 Mil (As of Dec. 2023)

View and export this data going back to 2006. Start your Free Trial

What is LeMaitre Vascular Total Inventories?

LeMaitre Vascular's total inventories for the quarter that ended in Dec. 2023 was $52.3 Mil. LeMaitre Vascular's average total inventories from the quarter that ended in Sep. 2023 to the quarter that ended in Dec. 2023 was $51.8 Mil.

In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. LeMaitre Vascular's Net-Net Working Capital per share for the quarter that ended in Dec. 2023 was $4.53.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. LeMaitre Vascular's Days Inventory for the three months ended in Dec. 2023 was 302.64.

Inventory Turnover measures how fast the company turns over its inventory within a year. LeMaitre Vascular's Inventory Turnover for the quarter that ended in Dec. 2023 was 0.30.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. LeMaitre Vascular's Inventory-to-Revenue for the quarter that ended in Dec. 2023 was 1.06.

LeMaitre Vascular Total Inventories Historical Data

The historical data trend for LeMaitre Vascular's Total Inventories can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LeMaitre Vascular Total Inventories Chart

LeMaitre Vascular Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Inventories

Get a 7-Day Free Trial

34.63

39.17

40.65

45.28

52.33

LeMaitre Vascular Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Total Inventories	Get a 7-Day Free Trial															45.28	48.87	49.10	51.26	52.33

LeMaitre Vascular Total Inventories Calculation

Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.

LeMaitre Vascular (NAS:LMAT) Total Inventories Explanation

Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.

1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.

LeMaitre Vascular's Net-Net Working Capital Per Share for the quarter that ended in Dec. 2023 is

	Net-Net Working Capital Per Share (Q: Dec. 2023 )
=	(Cash And Cash Equivalents	+	0.75 * Accounts Receivable	+	0.5 * Total Inventories	-	Total Liabilities
-	Preferred Stock	-	Minority Interest)	/	Shares Outstanding (EOP)
=	(105.074	+	0.75 * 25.064	+	0.5 * 52.333	-	48.878
-	0	-	0)	/	22.3272
=	4.53

2. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

LeMaitre Vascular's Days Inventory for the three months ended in Dec. 2023 is calculated as:

Days Inventory	=	Average Total Inventories (Q: Dec. 2023 )	/	Cost of Goods Sold (Q: Dec. 2023 )	*	Days in Period
	=	51.7985	/	15.618	*	365 / 4
	=	302.64

3. Inventory Turnover measures how fast the company turns over its inventory within a year.

LeMaitre Vascular's Inventory Turnover for the quarter that ended in Dec. 2023 is calculated as

Inventory Turnover	=	Cost of Goods Sold (Q: Dec. 2023 )	/	Average Total Inventories (Q: Dec. 2023 )
	=	15.618	/	51.7985
	=	0.30

4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

LeMaitre Vascular's Inventory to Revenue for the quarter that ended in Dec. 2023 is calculated as

Inventory-to-Revenue	=	Average Total Inventories (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	51.7985	/	48.883
	=	1.06

Be Aware

Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.

When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.

Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.

LeMaitre Vascular Total Inventories Related Terms

Thank you for viewing the detailed overview of LeMaitre Vascular's Total Inventories provided by GuruFocus.com. Please click on the following links to see related term pages.

LeMaitre Vascular (LeMaitre Vascular) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » LeMaitre Vascular Inc (NAS:LMAT) » Definitions » Total Inventories

Comparable Companies

Traded in Other Exchanges

LHU:Germany

Address

63 Second Avenue, Burlington, MA, USA, 01803

Website

https://www.lemaitre.com

LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are primarily used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. The firm's lower extremities product line contributes the largest proportion of revenue, followed by the carotid product line. LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches, and vessel closure systems. LeMaitre generates the majority of its revenue in the United States.

Executives

George W Lemaitre	director, 10 percent owner, officer: Chairman, President and CEO	342 BUNKER HILL STREET, #2B, CHARLESTOWN MA 02129
Bridget A Ross	director	C/O HENRY SCHEIN, INC., 135 DURYEA ROAD, MELVILLE NY 11747
John A Roush	director	C/O GSI GROUP INC., 125 MIDDLESEX TURNPIKE, BEDFORD MA 01730-1409
Lawrence J Jasinski	director	SOTEIRA INC., 14 TECH CIRCLE, NATICK MA 01760
David B Roberts	director, officer: CFO and Director	55 BRADFORD STREET, NEEDHAM MA 02492
Trent G Kamke	officer: Senior V. P., Operations	61 WILLOWDEAN AVENUE, WEST ROXBURY MA 02132
Martha Shadan	director	9201 W BROADWAY AVE, #650, MINNEAPOLIS MN 55445
Pellegrino Joseph P Jr	officer: Executive V.P. Finance	68 BEACON STREET, BOSTON MA 02108
Michael H Thomas	director	P.O. BOX 2207, NOKOMIS FL 34274-2207
Peter R Gebauer	officer: President, International OP	AM WALDFELD 17, BAD SODEN 2M 65812
Michael T Wijas	officer: VP of Sales, The Americas	C/O LEMAITRE VASCULAR, INC., 63 SECOND AVENUE, BURLINGTON MA 01803
Lemaitre Cornelia W	director, officer: V.P., Human Resources,Director	8 SUNSET ROCK ROAD, ANDOVER MA 01810
Russell D Hays	director	C/O BIOSOURCE INTERNATIONAL INC, 542 FLYNN RD, CAMARILLO CA 93012
Robert V Linden	officer: VP, North American Sales	236 WOODEN BRIDGE ROAD, HOLLAND PA 18966
Thorndike William N Jr	director	HOUSATONIC PARTNERS, 800 BOYLSTON STREET, SUITE 2220, BOSTON MA 02199